Kohji Fukunaga

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 4 EPO patents. Top assignees: Kyowa Hakko Bio Co., Ltd., Tohoku University, Okayama University. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohji Fukunaga. Retrieved from https://idiyas.com/inventor/kohji-fukunaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Miyagi, JP (2015 - 2023)
Sendai, JP (2019 - 2023)

Company Filing History:

3 out of 104

Kyowa Hakko Bio Co., Ltd.

where one patent can have more than one assignee

Years Active: 2015-2023

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11738037 - Agent for preventing or improving decline in brain function (2023-08-29),

2. 11608313 - Adamantylmethylamine derivative and use thereof as pharmaceutical (2023-03-21),

3. 10905705 - Agent for preventing or improving decline in brain function (2021-02-02),

4. 10709688 - Agent for treating synucleinopathy (2020-07-14),

5. 10369186 - Method of treating decline in brain function comprising coadministration of citrulline and glutathione (2019-08-06),

6. 9173878 - Brain function improving agent (2015-11-03),

Title: Kohji Fukunaga: Innovator in Cognitive Health

Introduction

Kohji Fukunaga is a notable inventor based in Miyagi, Japan, recognized for his contributions to cognitive health through innovative pharmaceutical compositions. With a total of six patents to his name, Fukunaga has made significant strides in the field of neuroscience and cognitive function improvement.

Latest Patents

Fukunaga's latest patents include an agent for preventing or improving the decline in brain function. This invention aims to address various cognitive impairments such as decreased perception ability, memory learning ability, and concentration. The active ingredients in this agent include citrulline and citicoline, which work to protect brain neuronal cells. Another significant patent involves an adamantylmethylamine derivative, which provides a pharmaceutical composition for treating or preventing cognitive diseases or disorders.

Career Highlights

Throughout his career, Kohji Fukunaga has worked with prominent organizations such as Kyowa Hakko Bio Co., Ltd. and Tohoku University. His work in these institutions has allowed him to advance his research and develop innovative solutions for cognitive health.

Collaborations

Fukunaga has collaborated with notable colleagues, including Kota Kumagai and Masahiko Morita, to further enhance his research and development efforts in the field of cognitive health.

Conclusion

Kohji Fukunaga's innovative work in cognitive health and his impressive portfolio of patents highlight his dedication to improving brain function and addressing cognitive disorders. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.